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June Supplement 201014S Abstractsclinical variables that can distinguish these individuals. The
purpose of the current study was to identify kidney mor-
phological features that predict a favorable blood pressure
(BP) response to RAS.
Methods: The study cohort consisted of 97 patients
who underwent RAS over 9 years. Patients were catego-
rized as “responders” based on modified AHA guide-
lines: Bp  160/90 mm Hg on fewer anti-hypertensive
medications or diastolic Bp  90 mm Hg on the same
medications. Renal volume was estimated as kidney
length x width x depth/2 based on preoperative CTA or
MRA.
Results: The mean age of the cohort was 68 1 years.
A favorable BP response was observed in 33 of 97 patients
(34%). Ipsilateral renal volume was significantly greater for
responders, compared to nonresponders (152 6 vs 132
4 cm3; p  .0049), whereas kidney length, width, and
depth did not discriminate responders from nonre-
sponders. No patient with a renal volume less than 75 cm3
was a BP responder. There was a highly significant associ-
ation between renal volume and response to RAS (Figure;
Chi square for trend; p  .0035).
Conclusions: A larger ipsilateral renal volume por-
tends a greater probability of a favorable BP response to
RAS. Conversely, a renal volume less than 75 cm3 defined
the threshold below which a kidney is unlikely to benefit
from RAS. These data suggest that renal volume should be
considered in patient selection for RAS.
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SS21.
The Contemporary Management of Splenic Artery An-
eurysms
Ryan O. Lakin, James F. Bena, Timur P. Sarac, Samir Shah,
Leonard P. Krajewski, Sunita D. Srivastava, Daniel G. Clair,
Vikram S. Kashyap. Vascular Surgery, Cleveland Clinic,
Cleveland, OHObjectives: The natural history of splenic artery aneu-
rysms (SAA) is poorly delineated. The objective of this
study was to review our experience with observation and
treatment of SAA.
Methods:Between 1996-2009, 129 patients with SAA
were evaluated. 64 patients underwent open surgical repair
(n 13) or endovascular coil/glue ablation (n 51) while
65 patients underwent serial observation. Statistical analy-
ses and Kaplan-Meier estimates for survival were per-
formed. Mortality was verified via the Social Security data-
base.
Results: Patients (61  11 years, 69% female) were
investigated for abdominal symptoms (50%) or had the
incidental finding of SAA (mean size 23  14 mm).
Seven patients (5.4%) presented with rupture, and were
treated emergently with 2 perioperative mortalities
(29%). Patients requiring SAA treatment were more
likely male (42 vs 20%, p  0.011), younger (58.5 vs
63.8 years, p  0.006), and trended towards current
smoking (16 vs 5%, p  0.07). The mean aneurysm size
was 3.1 cm for the treated group and 1.5 cm for the
observed group (p  0.001). Endovascular repair was
safe and durable with thrombosis or a regression of SAA
size on follow-up CT imaging (mean 1.2 years). The
mean rate of growth for observed SAA was 0.07mm/
year. Ten-year survival was 88.2% (95% CI: 79.8, 97.5)
for all patients (observed group 93.4%, treated group
84.4%, p  0.23). No late aneurysm related mortality
was identified.
Conclusions: Ruptured SAA are lethal. Large SAA can
undergo endovascular ablation safely with durable SAA
regression. Smaller SAA (2 cm) grow slowly and carry a
negligible rupture risk.
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Himanshu J. Patel, Mark Hemmila, David M. Williams,
G. M. Deeb. University of Michigan Hospitals, Ann Arbor,
MI
Objectives: Previous studies have focused on early
outcomes of open (DTAR) and endovascular (TEVAR)
repair for blunt aortic injury (BTAI). Late results remain
ill-defined and are the focus of this report.
Methods: 108 patients (1992-2009) underwent repair
for BTAI. Mean age was 38.7 years (74.1% male). DTAR
was performed in 90, with left heart bypass (85) or hypo-
thermic arrest (5). TEVAR was used in 18 of 44 treated
since 2002. Since 1997, repair was selectively delayed in 53
of 74 treated in that interval. The primary outcome was
vital status (100% followup, mean 100 months).
Results: Mean Injury Severity Score (ISS) was 39.5.
30-day mortality was 5.5% (6). Early morbidity included
permanent spinal cord ischemia (2, 1.8%), stroke (3, 2.8%)
and need for permanent dialysis (2, 1.8%). Independent
predictors of a composite outcome of early mortality and
these morbidities included age60 years (p  0.007) and
elevated preoperative creatinine (p 0.04), but not type of
repair (p  0.39) nor ISS (p  0.37). 10 yr Kaplan-Meier
survival was 85.1%. Independent predictors of late mortal-
ity included age60 years (p  0.02), and the presence of
diabetes (p 0.04). In a comparative analysis, the TEVAR
group was older (DTAR 36.8 years vs TEVAR 48.2 years,
p  0.01), more frequently had coronary artery disease
(DTAR 3.3% vs TEVAR 22.2%, p  0.01), and a higher
incidence of delayed repair (DTAR 69% vs TEVAR 89%,
p  0.001). When stratified by age, there was no survival
difference based upon repair type (p0.4). Endograft col-
lapse occurred in 1 necessitating endovascular reinterven-
tion. Freedom from aortic reintervention at 4 years was
higher after open repair (DTAR 100% vs TEVAR 94%, p
0.03).
Conclusions: Repair for BTAI has excellent early and
late results, regardless of therapeutic approach. Al-
though TEVAR has an increased risk for reintervention,
factors other than treatment strategy impact late survival.
These data support the growing role of an endoluminal
approach for BTAI in anatomically appropriate patients.
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Left Renal Vein Transposition for the Treatment of
Nutcracker Syndrome
Donald Baril, Patricio Polanco, Michel Makaroun, Rabih
Chaer. Vascular Surgery, University of Pittsburgh Medical
Center, Pittsburgh, PA
Background: Nutcracker syndrome, defined as com-
pression of the left renal vein between the superior mesen-
teric artery and the aorta leading to flank pain and hematu-
ria, was first described in 1950. Additional symptoms may
include a left-sided varicocele, pelvic congestion syndrome,
and orthostatic proteinuria. The diagnosis is primarily clin-
ical but relies on information obtained by axial imaging
along with duplex and venography. Indications for treat-
ment include significant hematuria, severe flank pain, and
renal functional impairment. Treatment options include
left renal vein transposition, transluminal angioplasty and
stenting, renal autotransplantation, and nephropexy.
Technical Description: We present the case of a 23-
year-old male who presented with a 9-month history of left
flank pain and hematuria. He underwent an extensive
work-up including CT, MR, duplex ultrasound, and
venography. Based on these studies and his clinical presen-
tation he was diagnosed with Nutrcracker syndrome. He
subsequently underwent open left renal vein transposition.
He recovered well and was discharged on postoperative day
5. At one- and three-month follow-up, he had markedly
diminished flank pain and no further hematuria. Duplex
ultrasound demonstrated a widely patent left renal vein.
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Objectives: Increased utilization of CT angiography in
the work-up of trauma patients has led to increasing diag-
nosis ofMinimal Aortic Injury (MAI). The aim of this study
is to review the outcomes of patients with Blunt Aortic
Injury (BAI) that were treated nonoperatively at our insti-
tution over the past decade.
Methods: All patients admitted with BAI from Jan 1,
1999 to Dec 31, 2008 were identified from a review of
medical records. Patients were then analyzed based on type
of aortic injury, method of repair, ISS, morbidity, and
mortality. Type of injury was determined by review of
imaging and divided into the following categories: MAI -
absence of “external aortic contour abnormality” (EACA)
with small intimal injury 10mm, Large Intimal Flap
(LIF)- absence of EACA with intimal injury 10mm),
